InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 5,158,932 | 6,954,834 | 9,331,077 | 11,075,871 |
| Short-term investments | 41,625 | 42,675 | 42,859 | 43,384 |
| Accounts receivable, net | NaN | 182,967 | 343,469 | 465,104 |
| Inventories, net | NaN | 947,898 | 890,807 | 961,173 |
| Prepaids and other current assets | 617,211 | 660,280 | 191,755 | 321,747 |
| Current assets of discontinued operations | 1,070,313 | NaN | NaN | NaN |
| Total current assets | 6,888,081 | 8,788,654 | 10,799,967 | 12,867,279 |
| Property and equipment | NaN | NaN | NaN | 2,330,559 |
| Less accumulated depreciation and amortization | NaN | NaN | NaN | 1,338,360 |
| Property, equipment and rou assets, net | 642,884 | 764,254 | 881,549 | 992,199 |
| Intangible assets | 2,927,420 | 2,927,420 | 2,927,420 | 2,927,420 |
| Less accumulated amortization | 1,428,947 | 1,388,844 | 1,347,851 | 1,306,858 |
| Intangible assets, net | 1,498,473 | 1,538,576 | 1,579,569 | 1,620,562 |
| Other assets | 104,368 | 100,000 | 100,000 | 100,000 |
| Total assets | 9,133,806 | 11,191,484 | 13,361,085 | 15,580,040 |
| Accounts payable and accrued liabilities | 1,011,551 | 1,071,871 | 1,130,219 | 1,404,283 |
| Current portion of lease obligations | 389,381 | 408,122 | 424,765 | 435,507 |
| Current liabilities of discontinued operations | 810,334 | NaN | NaN | NaN |
| Total current liabilities | 2,211,266 | 1,479,993 | 1,554,984 | 1,839,790 |
| Lease obligations, net of current portion | 30,766 | 123,827 | 215,478 | 305,755 |
| Total liabilities | 2,242,032 | 1,603,820 | 1,770,462 | 2,145,545 |
| Common shares, no par value, unlimited authorized shares 3,314,063 and 2,002,186 as of march 31, 2026 and june 30, 2025, respectively, issued and outstanding | 92,578,071 | 92,046,396 | 91,806,396 | 91,221,174 |
| Additional paid-in capital | 38,144,484 | 38,405,713 | 38,620,449 | 39,322,644 |
| Accumulated deficit | -123,959,350 | -120,993,014 | -118,964,791 | -117,237,892 |
| Accumulated other comprehensive income | 128,569 | 128,569 | 128,569 | 128,569 |
| Total shareholders equity | 6,891,774 | 9,587,664 | 11,590,623 | 13,434,495 |
| Total liabilities and shareholders equity | 9,133,806 | 11,191,484 | 13,361,085 | 15,580,040 |